KLF4 and cancer: More importantly, we provided evidence that KLF4 down-regulation suppressed the transcription of p110δ, a major catalytic subunit of PI3K in cancer cells [20], so to directly reduce PI3K/Akt pathway activity and eventually suppressed the phosphorylation of both Akt and p21 and stimulated the nuclear translocation of p21.